Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

MyNCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

1,095 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Single-subject structural cortical networks in clinically isolated syndrome.
Collorone S, Prados F, Hagens MH, Tur C, Kanber B, Sudre CH, Lukas C, Gasperini C, Oreja-Guevara C, Andelova M, Ciccarelli O, Wattjes MP, Ourselin S, Altmann DR, Tijms BM, Barkhof F, Toosy AT; MAGNIMS Study Group. Collorone S, et al. Among authors: Barkhof F. Mult Scler. 2019 Jul 24:1352458519865739. doi: 10.1177/1352458519865739. Online ahead of print. Mult Scler. 2019. PMID: 31339446
Specific power calculations for magnetic resonance imaging (MRI) in monitoring active relapsing-remitting multiple sclerosis (MS): implications for phase II therapeutic trials.
Truyen L, Barkhof F, Tas M, Van Walderveen MA, Frequin ST, Hommes OR, Nauta JJ, Polman CH, Valk J. Truyen L, et al. Among authors: Barkhof F. Mult Scler. 1997 Jan;2(6):283-90. doi: 10.1177/135245859700200604. Mult Scler. 1997. PMID: 9065919
The diagnostic value of magnetic resonance imaging and technetium 99m-HMPAO single-photon-emission computed tomography for the diagnosis of Alzheimer disease in a community-dwelling elderly population.
Scheltens P, Launer LJ, Barkhof F, Weinstein HC, Jonker C. Scheltens P, et al. Among authors: Barkhof F. Alzheimer Dis Assoc Disord. 1997 Jun;11(2):63-70. doi: 10.1097/00002093-199706000-00002. Alzheimer Dis Assoc Disord. 1997. PMID: 9194952
Single-dose gadolinium with magnetization transfer versus triple-dose gadolinium in the MR detection of multiple sclerosis lesions.
van Waesberghe JH, Castelijns JA, Roser W, Silver N, Yousry T, Lycklama à Nijeholt GJ, Adèr HJ, Uitdehaag BM, Radue EW, Polman CH, Kappos L, Miller DH, Barkhof F. van Waesberghe JH, et al. Among authors: Barkhof F. AJNR Am J Neuroradiol. 1997 Aug;18(7):1279-85. AJNR Am J Neuroradiol. 1997. PMID: 9282855
A phase II trial of anti-CD4 antibodies in the treatment of multiple sclerosis.
van Oosten BW, Lai M, Barkhof F, Miller DH, Moseley IF, Thompson AJ, Hodgkinson S, Polman CH. van Oosten BW, et al. Among authors: Barkhof F. Mult Scler. 1996 Jul;1(6):339-42. doi: 10.1177/135245859600100611. Mult Scler. 1996. PMID: 9345413 Clinical Trial.
1,095 results
Jump to page
Feedback